AdvanceMarketAnalytics, a global market research and consulting organization, have released a new study titled "Radiodermatitis market - Global outlook to 2026".
Industries constant focus on reducing the operational cost and increased attention on core business, and need to improve scalability are expected to shape the Global Radiodermatitis market to grow at a CAGR of 3.93%.

The Therapy, such as Radiation Therapy, is boosting the Radiodermatitis market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.

The Severity, such as Grade 1, is boosting the Radiodermatitis market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.

According to Analyst at AMA Research, the Global Radiodermatitis market will experience significant growth during the forecast period due to potential opportunities lying in the market such as . Some of the important driving forces are “Owing to Increased Disposable Income among Urban Populations, Improving Healthcare Infrastructure in Several Emerging Economies leading to a large number of the pool of patients, Growth in the number of cancer patients and Increase in the geriatric population”.
 

As the cases of Cancer escalate across the world, the demand in the Global Radiodermatitis is anticipated to propel the market growth. Cancer patients are more likely to develop radiation-induced dermatitis owing to frequent radiation treatments. Radiodermatitis, also known as radiation dermatitis, is a peculiar symptom caused as a result of radiation therapy pertaining to the treatment of cancerous as well as noncancerous conditions and has a significant negative impact on a patient’s physical functionalities and quality of life. It has been estimated that in developed countries, nearly half of the patients who receive treatment for cancer are subjected to radiation therapy during the illness, and about all of them experience some degree of skin reaction. Radiodermatitis is a side effect of external beam ionizing radiation caused by radiotherapy for underlying malignancies. Development and severity of radiodermatitis are associated with multiple patient and treatment factors such as total radiation dose, duration of radiotherapy, and treatment with chemotherapy.

The report provides an in-depth analysis and forecast about the industry covering the following key features:
o Industry outlook including current and future market trends, drivers, restraints, and emerging technologies
o Analyses the Global Radiodermatitis market by Type (Topical (Corticosteroids, Hydrophilic Creams, and Antibiotics), Oral Medication (Corticosteroids, Oral Analgesics, and Antibiotics), Dressings (Hydrogel, Hydrocolloid, No Sting Barrier Film, Honey Impregnated Gauze, and Silicone Coated Dressing) and Others (GM-CSF gauze, silver leaf dressing, etc.)), by Application (Retail Pharmacies, Hospital Pharmacy and Online stores) and major geographies with country level break-up that includes South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
o Analyzes the top 10 players in terms of market reach, business strategy, and business focus
o Provides stakeholders’ insights and key trends (current and future) of the market